Observational quality control study: insourcing multi-PCR-impact on the use of anti-infectives for patients with pleocytosis

The shortened average LOS after changing the diagnostic pathway increased direct costs for test kits. However, these costs were by far outweighed the economical benefit of being able to treat more patients in the same time. This analysis should be replicated in a different Medical Care System than the one in which this analysis has been calculated.